PMH40 COST-UTILITY ANALYSIS (CUA) OF SERTINDOLE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND IN GENERAL POPULATION OF SCHIZOPHRENIC PATIENTS AND POPULATION OF PATIENTS INTOLERANT TO AT LEAST ONE OTHER ANTIPSYCHOTIC AGENT- A FIVE-YEAR MARKOV ...
Abstract
Authors
J Walczak J Stelmachowski G Obrzut G Nogas